The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127112961 12711296 1 I 20160901 20160902 20160902 EXP CA-ROCHE-1824389 ROCHE 64.00 YR M Y 66.00000 KG 20160902 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127112961 12711296 1 PS Obinutuzumab OBINUTUZUMAB 1 Intravenous (not otherwise specified) U 125486 SOLUTION FOR INFUSION
127112961 12711296 2 SS ALLOPURINOL. ALLOPURINOL 1 Unknown THERAPY DURATION: 18 DAYS U 0
127112961 12711296 3 SS BENDAMUSTINE BENDAMUSTINE 1 Intravenous (not otherwise specified) U 0 163.75 MG
127112961 12711296 4 C ASPIRIN. ASPIRIN 1 0
127112961 12711296 5 C BENADRYL DIPHENHYDRAMINE HYDROCHLORIDE 1 0
127112961 12711296 6 C DEMEROL MEPERIDINE HYDROCHLORIDE 1 0
127112961 12711296 7 C DOCUSATE DOCUSATE 1 0
127112961 12711296 8 C GLYCERIN. GLYCERIN 1 0
127112961 12711296 9 C GRANISETRON HYDROCHLORIDE. GRANISETRON HYDROCHLORIDE 1 Unknown 0 2 MG
127112961 12711296 10 C GRAVOL DIMENHYDRINATE 1 0
127112961 12711296 11 C LIPITOR ATORVASTATIN CALCIUM 1 0
127112961 12711296 12 C LORAZEPAM. LORAZEPAM 1 0
127112961 12711296 13 C METFORMIN METFORMIN HYDROCHLORIDE 1 Unknown 0
127112961 12711296 14 C MORPHINE MORPHINE 1 0
127112961 12711296 15 C NIFEDIPINE. NIFEDIPINE 1 0
127112961 12711296 16 C NIFEDIPINE. NIFEDIPINE 1 0
127112961 12711296 17 C OXYCODONE OXYCODONE 1 0
127112961 12711296 18 C PREDNISONE. PREDNISONE 1 Unknown THERAPY DURATION: 9 DAYS 0
127112961 12711296 19 C PROCHLORPERAZINE. PROCHLORPERAZINE 1 0
127112961 12711296 20 C RAMIPRIL. RAMIPRIL 1 0
127112961 12711296 21 C RESTORALAX POLYETHYLENE GLYCOL 3350 1 Unknown 0
127112961 12711296 22 C STEMETIL PROCHLORPERAZINE MALEATE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127112961 12711296 1 B-cell lymphoma
127112961 12711296 2 Prophylaxis
127112961 12711296 3 B-cell lymphoma
127112961 12711296 4 Coronary artery bypass
127112961 12711296 6 Chills
127112961 12711296 7 Constipation
127112961 12711296 10 Nausea
127112961 12711296 11 Hypercholesterolaemia
127112961 12711296 12 Anxiety
127112961 12711296 13 Diabetes mellitus
127112961 12711296 14 Proctalgia
127112961 12711296 15 Hypertension
127112961 12711296 16 Carotid artery bypass
127112961 12711296 17 Abdominal pain
127112961 12711296 20 Hypertension
127112961 12711296 21 Constipation

Outcome of event

Event ID CASEID OUTC COD
127112961 12711296 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127112961 12711296 Pyrexia
127112961 12711296 Rash maculo-papular

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found